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Abstract
Background: The NS1 protein of avian influenza virus (AIV) is an important virulent factor of AIV. It has been shown
to counteract host type I interferon response, to mediate host cell apoptosis, and to regulate the process of protein
synthesis. The identification of AIV epitopes on NS1 protein is important for understanding influenza virus
pathogenesis.
Results: In this paper, we describe the generation, identification, and epitope mapping of a NS1 protein-specific
monoclonal antibody (MAb) D9. First, to induce the production of MAbs, BALB/c mice were immunized with a
purified recombinant NS1 expressed in E. coli. The spleen cells from the immunized mice were fused with myeloma
cells SP2/0, and through screening via indirect ELISAs, a MAb, named D9, was identified. Western blot assay results
showed that MAb D9 reacted strongly with the recombinant NS1. Confocal laser scanning microscopy showed that
this MAb also reacts with NS1 expressed in 293T cells that had been transfected with eukaryotic recombinant
plasmids. Results from screening a phage display random 7-mer peptide library with MAb D9 demonstrated that
it recognizes phages displaying peptides with the consensus peptide WNLNTV–VS, which closely matches the
182WNDNTVRVS190 of AIV NS1. Further identification of the displayed epitope was performed with a set of truncated
polypeptides expressed as glutathione S-transferase fusion proteins, and the motif 182WNDNT186 was defined as the
minimal unit of the linear B cell epitope recognized by MAb D9 in western blot assays. Moreover, homology
analysis showed that this epitope is a conserved motif among AIV.
Conclusions: We identified a conserved linear epitope, WNDNT, on the AIV NS1 protein that is recognized by MAb
D9. This MAb and its epitope may facilitate future studies on NS1 function and aid the development of new
diagnostic methods for AIV detection.
Background
Avian influenza (AI) is an infectious disease caused by
avian influenza virus (AIV), a member of the Orthomy-
xoviridae family [1, 2]. AIV is an enveloped, negative-
stranded, segmented RNA virus. The AIV genome consists
of eight RNA segments that vary in size ranging from 890
to 2,341 bases and code for 11 known proteins. AIV pro-
duces 11 viral proteins that can be divided into three main
categories: surface proteins, internal proteins, and non-
structural proteins [3]. The viral particle contains three
surface proteins: hemagglutinin (HA), neuraminidase
(NA), and matrix 2 (M2) proteins. The internal proteins
of the viral particle include three polymerase proteins, PA,
PB1, and PB2, as well as nucleoprotein, matrix 1 (M1),
and nonstructural protein 2 (NS2). Nonstructural protein
1 (NS1) is a protein that is not packaged into the virus
particle, although it is produced in large quantities in in-
fected cells [4, 5]. NS1 protein plays an important role in
virus infection and in the viral replication process. It has
been shown to counteract the host type I interferon re-
sponse [6], to mediate host cell apoptosis [7, 8], and to
regulate the process of protein synthesis [9].
AIV can be classified into high (HPAIV) and low
(LPAIV) pathogenic avian influenza viruses depending
on the severity of the diseases that they cause, ranging
from asymptomatic infections to acute systemic diseases
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and even death [10]. During the last decades, HPAIV
has been involved in several outbreaks in poultry and
wild birds around the world [11]. The epidemic of AI
represented by the H5N1 subtype continues to cause se-
vere losses for the poultry industry and threatens both
human health and public health worldwide. Vaccination
against AIV, despite being a powerful tool for disease
control, makes distinguishing between infected and vac-
cinated animals through serological tests difficult [12].
To overcome this problem, several studies have focused
on a differentiation of infected and vaccinated animals
program of AI, which is mostly centralized on the NS1
protein-based antibody response [13]. Our study aimed
to contribute to this program by generating a monoclo-
nal antibody (MAb) to NS1 and identifying the epitope
recognized by this MAb.
Results
Expression and characterization of a recombinant AIV
NS1 protein
The recombinant NS1 protein was expressed predomin-
antly as an inclusion body in E. coli after IPTG induc-
tion. It was purified by affinity chromatography and
analyzed by SDS-PAGE (Fig. 1). Western blot analysis
indicated that the purified recombinant NS1 protein,
which was encoded by the gene from the H5N1 virus,
was reactive with AIV-positive sera (Fig. 2). These re-
sults show that the purified recombinant NS1 protein
was a suitable antigen for immunization and hybridoma
screening.
Production and characterization of NS1-specific MAb
Purified recombinant NS1 protein expressed in E. coli
was used to immunize BALB/c mice. After cell fusion
and screening, several hybridoma cell lines were ob-
tained, which produced NS1-specific MAbs. One MAb
produced by the line, designated as D9, was selected for
its strong reactivity with recombinant NS1 protein in in-
direct ELISA (data not shown) and western blot (Fig. 3a)
assays. Furthermore, confocal laser scanning microscopy
results show that MAb D9 had a strong reactivity with
NS1 expressed in 293T cells transfected with eukaryotic
recombinant plasmids (Fig. 3b). MAb D9 was composed
of an IgG1 heavy chain paired with a κ-type light chain,
as determined using the SBA Clonotyping™ System/HRP
Kit according to the manufacturer’s instructions. The
titers of MAb D9 in hybridoma cell culture supernatants
and in ascites were measured by indirect ELISA and
determined to be 1:1,000 and 1:100,000, respectively.
Phage enrichment
To define the MAb binding epitope, a phage-displayed
7-mer random peptide library was screened with MAb
D9. The output to input ratios of the three rounds of
biopanning were 2.2 × 10−4, 8.5 × 10−3, and 3.4 × 10−2, re-
spectively, which indicated an enrichment of phages
bound to MAb D9. After three successive rounds of
biopanning, the selected 24 phage clones showed higher
reactivity by phage ELISA with MAb D9 than with a
negative control of irrelevant MAb (data only shown
for phage clones that were successfully sequenced;
Fig. 4).
Fig. 1 SDS-PAGE analysis of the recombinant NS1 protein and
purified NS1 protein. M, Marker. Lane 1, proteins expressed in E. coli
without IPTG induction. Lane 2, proteins expressed in E. coli with
IPTG induction. Lane 3, purified recombinant NS1 protein
Fig. 2 Western blot analysis of purified recombinant NS1 protein.
M, Marker. Lane 1, the binding of purified recombinant NS1 protein
with AIV-negative chicken sera. Lane 2, the binding of purified
recombinant NS1 protein with AIV-positive chicken sera
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Epitope prediction
The selected 24 phage clones were sequenced and ana-
lyzed by DNASTAR Lasergene program (Windows ver-
sion; DNASTAR Inc., Madison, WI, USA). The MAb D9
recognized phages displaying peptides with the consen-
sus peptide WNLNTV–VS, which was substantially
matched with 182WNDNTVRVS190 of AIV NS1 protein
(Table 1).
Epitope identification
To confirm the linear epitope recognized by MAb D9,
the motif WNDNTVRVS was expressed as glutathione
S-transferase (GST) fusion protein GST-wt. Western
blot analysis results show that MAb D9 reacted with
GST-wt (Fig. 5a). To further identify the minimal epi-
tope, six truncated motifs, GST-wtΔS, GST-wtΔVS,
GST-wtΔRVS, GST-wtΔVRVS, GST-wtΔTVRVS, and
GST-wtΔW, were expressed in E. coli and then subjected
to western blot with MAb D9. The results show that ex-
cept for GST-wtΔTVRVS and GST-wtΔW, the other
motifs were recognized by the MAb D9, suggesting that
the motif WNDNT represents a minimal unit for the re-
activity of the epitope recognized by MAb D9 (Fig. 5a).
Taken together, these results show that WNDNT is a
minimal linear B-cell epitope of AIV NS1 protein.
Reactivity of the identified epitope with AIV-positive
chicken sera
To verify whether the identified epitope could be recog-
nized by AIV-positive chicken sera, an indirect ELISA
assay was performed. 96-well plates were coated with
the protein GST-wtΔVRVS. The ELISA results indicated
that the identified epitope peptide WNDNT could be
recognized by the AIV-positive chicken sera but not by
AIV-negative chicken sera, revealing that the epitope
exhibited good reactivity and would be useful for the
diagnosis of AIV (Fig. 6).
Homology analysis
All sequences in the NCBI Influenza Virus Sequence
Database were aligned using clustal software to evalu-
ate the degree of conservation of the linear epitope
Fig. 3 The binding of MAb D9 with prokaryotic and eukaryotic expression of NS1 protein. The binding of MAb D9 with prokaryotic purified
recombinant NS1 protein (a) and NS1 protein expressed in 293T cells transfected with eukaryotic recombinant plasmids (b). 1. The binding of
MAb D9 with NS1 protein expressed in 293T cells. 2. The binding of negative serum with NS1 protein expressed in 293T cells
Fig. 4 Detection of the selected phages for MAb D9 binding by phage ELISA. After three successive rounds of biopanning, phage ELISA was
performed for further identification of the positive phage clones that were successfully sequenced. An irrelevant MAb was used as a negative
control. Error bars represent the standard deviation of the results from three replicate experiments
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recognized by MAb D9 among AIV. The resulting
alignment indicated that the epitope 182WNDNT186 is
highly conserved among different isolates, although in
some sequences a single amino acid substitution was
identified (the first N is replaced by S, the D is replaced by
G or N, or the T is replaced by S). Based on these amino
acid substitutions, we expressed four mutant motifs, GST-
T186S, GST-N183S, GST-D184G, and GST-D184N, as
GST fusion proteins. Western blot assays indicated that
MAb D9 could recognize all of the fusion proteins
(Fig. 5b). The amino acid substitutions at different sites
within the epitope among some isolates did not affect the
reactivity of MAb D9 with the epitope, which sug-
gested that MAb D9 was broadly recognized by almost all
AIV NS1.
Discussion
As with other viruses, the antigenic structures of AIV
are recognized by the immune system through binding
of its epitopes by the surface receptors on specific clones
of T cells or B cells, inducing a humoral and/or cell-
mediated immune response [14]. To our knowledge,
previous studies of epitopes against AIV have mainly fo-
cused on the HA protein rather than on the NS1 protein
[15–17]. Thus, the identification of an AIV epitope on
NS1 protein is important for understanding influenza
virus pathogenesis. This finding will facilitate further
study on the molecular mechanisms responsible for viral
stimulation of the immune response.
Table 1 Sequence comparison of random peptide inserts
displayed on the positive phage
Phage clones Amino acid sequence of the insert
1 G W S L S T - - V -
3 - W R D N A I A - -
4 - W N L N T T N - -
6 - W N L N H I F - -
8 - W S Q T T - - V S
9 - W G E N T I W - -
11 - F N L N T A M - -
12 - W N S N A I - - S
13 A W N F N S Q - - -
14 - W N F - T A R E -
15 - W N Q N T A - - S
16 - W T Y T T F E -
19 - W S Q T T - - V S
20 - W N Q N T - - V S
24 - W N S N A I - - S
Consensus - W N L N T V - V S
AIV-NS1 E W N D N T V R V S
Note: Conservative amino acids are bold
Fig. 5 Reactivity of the GST-fusion proteins with the MAb D9. Western blots were performed to test the reactivity of MAb D9 with the GST-fusion
proteins containing wild-type and truncated (a) or mutant (b) motifs derived from the motif WNDNTVRVS. Marker: PageRuler™ Prestained Protein
Ladder. GST-7wt: fusion protein containing the motif WNDNTVRVS, GST-wtΔS: WNDNTVRV, GST-wtΔVS: WNDNTVR, GST-wtΔRVS: WNDNTV,
GST-wtΔVRVS: WNDNT, GST-wtΔTVRVS: WNDN, GST-wtΔW-VRVS: NDNT, GST-T186S: WNDNS, GST-N183S: WSDNT, GST-D184G: WNGNT and
GST-D184N: WNNNT
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MAb combined with phage display is one of the most
widely used and fastest-growing tools for mapping epi-
topes [18, 19]. It has been successfully applied to identify
a variety of pathogenic microorganism epitopes. Com-
pared with other existing methods, phage display is a
simple, fast, and convenient method for mapping epi-
topes [20]. Moreover, the phage display peptide library
can be screened to affinity-select mimotopes, which are
peptides that mimic discontinuous epitopes [21]. Screen-
ing of a 12-mer peptide library was performed for the
identification of a conserved linear B-cell epitope of the
E2 glycoprotein N-terminus of classical swine fever virus
[22]. Sun et al. similarly screened a 12-mer peptide li-
brary using phage-display technology to define the linear
epitope recognized by West Nile virus C protein-specific
MAb [23]. Here, we used purified recombinant NS1
expressed in E. coli to generate MAb D9. Then, by
screening a phage display random 7-mer peptide library
with MAb D9, the motif WNDNTVRVS located from
AA182 to AA190 of the AIV NS1 protein was defined as
the linear epitope of MAb D9. Furthermore, by using a
set of truncated polypeptides expressed as GST fusion
proteins, we identified WNDNT as a minimal linear B-cell
epitope of AIV NS1 protein.
To investigate the conservation of the identified linear
epitope among AIV viruses, all sequences in the NCBI
Influenza Virus Sequence Database were aligned using
clustal software. There are 23,072 NS1 protein sequences
(6,854 sequences after identical sequences were collapsed)
in total in the database. 60.23 % of the sequences contain
the epitope WNDNT. 36.44 % of the sequences have a
unique amino acid substitution, with 6,061 sequences that
replace D with G, 2,265 sequences that replace T with S,
62 sequences that replace D with N, and 19 sequences
that replace the first N with S. Amino acid substitution or
lack of it was not related to the hosts and subtypes of the
viruses. These results show that the epitope is present
widely in influenza virus strains (Table 2). Among the mu-
tated amino acids, D, G, and N are polar amino acids and
N, S, and T are uncharged polar amino acids.
Many epitopes have been defined in the NS1 protein of
AIV viruses, and most of them have been mapped by
MAbs produced in mice immunized with recombinant
proteins or synthesized peptides. Among the previously-
mapped epitopes, there are seven epitopes that do not
overlap with the epitope identified in this study. These
epitopes are LEWNDNTVRVTETIQRFAWRNSDEDG
RLPLPPNQKR [24], EWNDNTVRVSETLQRFA [25, 26],
VLIGGLEWNDNTVRVSE [27–29], EWNDNTVRVSE
TLQR and LIGGLEWNDNTVRVS [30], GLEWNDNTV
[31], and EWNDNTVRV [32]. There are also three epi-
topes that contain part of the epitope identified in this
study. They are VKNAIGVLIGGLEWNDN [29], DEDVK
NAIGVLIGGLEWNDN [33], and NAVGVLIGGLEWN
DN [30]. Because none of these epitopes are completely
identical to the epitope described in this study, this new
epitope is another different linear epitope on the AIV NS1
protein. The MAb and its epitope described in this study
will facilitate further study on the function of NS1 and aid
in diagnostic method development for AIV detection.
Conclusions
This study identified the motif WNDNT as a conserved
linear epitope on the AIV NS1 protein that is recognized
by the MAb D9. This MAb and its epitope may facilitate
Table 2 Sequence comparison of the identified epitope among
AIV strains available in the NCBI Influenza Virus Sequence Database
Different variations Sequences Amino acid substitutions
No substitution 13895 W N D N T
Single substitution 6061 - - G - -
2265 - - - - S
62 - - N -
19 - S - - -
The rest 770
Total 23072
Fig. 6 ELISA analysis for reactivity of the identified epitope with
AIV-positive chicken sera. Expressed protein (the minimal epitope:
GST-wtΔVRVS) was used to coat the 96-well plates. AIV-positive
chicken sera was used to detect the coated proteins, AIV-negative
chicken sera was included as a negative control. Error bars represent
the standard error of the mean of the results from three
replicate experiments
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further study on the pathogenesis of AIV and aid in
diagnostic method development for AIV detection.
Methods
Ethics statement
Care of laboratory animals and animal experimentation
were performed in accordance with animal ethics guide-
lines and approved protocols. All animal studies were
approved by the Review Board of Harbin Veterinary Re-
search Institute of the Chinese Academy of Agricultural
Sciences and by the Animal Care and Use Committee of
Heilongjiang Province (SYXK (Hei) 2012–2067).
Plasmid and cells
The recombinant plasmid pET-NS1 containing the AIV
NS1 gene sequence was generated in our lab. The mye-
loma cells SP2/0 and 293T cells were both cultured in
Dulbecco’s modified Eagle’s medium (DMEM, GIBCO,
Grand Island, NY, USA) in a humidified 5 % CO2 at-
mosphere at 37 °C. All culture media were supple-
mented with 10 % heat-inactivated fetal bovine serum
(Hyclone, Thermo, Rockford, IL, USA) and antibiotics
(10,000 μg/mL of streptomycin and 10,000 units/mL of
penicillin, GIBCO).
Prokaryotic expression and purification of recombinant
AIV NS1 protein
The pET-NS1 was transformed into E. coli BL21 (DE3),
and transformed bacteria were identified using both re-
striction enzyme digestion and PCR. Further confirmation
was obtained by DNA sequencing. DE3 transformed with
pET-NS1 were cultured at 37 °C in culture medium (per
liter: 10 g tryptone, 5 g yeast extract, and 10 g NaCl,
adjusted pH to 7.0) supplemented with kanamycin
(100 μg/μL). After several hours of shaking, when the op-
tical density (OD 600 nm) was up to 0.6, isopropyl-D-1-
thiogalactopyranoside (IPTG, Takara, Dalian, China) was
added to the medium at a final concentration of 1 mM for
the induction of protein expression. Then, an additional
4 h incubation at 37 °C with agitation was performed.
After the cells were harvested by centrifugation at
10,000 × g for 10 min at 4 °C, the pelleted bacteria were
suspended in 10 mL phosphate-buffered saline (PBS)
and then lysed by sonication in an ice water bath. The
pellet was re-suspended with 10 mL of 1 × Binding Buffer
from the His-band purification kit (Novagen, Merck
KGaA, Darmstadt, Germany) plus 6 M urea. After an ice
water bath, the suspension was centrifuged at 16,000 × g
for 30 min. The supernatant was filtered by a 0.45-μm
filter membrane. The His-band purification kit was used
according to the manufacturer’s instructions for purifica-
tion of the NS1 protein. After Ni-charged binding, wash-
ing, and elution, the purified protein was ultrafiltered to
fold its structure. The purified protein was analyzed in
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and
visualized using Coomassie brilliant blue staining.
Western blots
Western blots were carried out to analyze the antigenic-
ity of the purified protein. After being separated by 10 %
SDS-PAGE, the purified protein was electrically trans-
ferred onto a polyvinylidenefluoride (PVDF) membrane.
Then, the membrane was blocked with 5 % skim milk in
PBS for 1 h at 37 °C, followed by incubation with AIV-
positive sera diluted in 5 % skim milk in PBS for 1 h
at 37 °C. After three washes with PBST (PBS contain-
ing 0.05 % Tween-20), the membrane was incubated with
a 1:4,000 dilution of horseradish peroxidase (HRP)-conju-
gated goat anti-chicken IgG (Sigma, St. Louis, MO, USA)
for 1 h at 37 °C. Color was developed with 3,3′-diami-
nobenzidinetetrahydrochloride (DAB) and the reaction
was stopped by rinsing with distilled water and drying the
membrane.
Production and identification of MAb against AIV NS1
protein
To prepare MAb against AIV NS1, six-week-old BALB/c
mice were intraperitoneally immunized with 100 μg puri-
fied recombinant NS1 protein expressed in E. coli emulsi-
fied with an equal volume of Freund’s complete adjuvant
(Sigma) and boosted with the same dose 2 weeks later.
Three days after the final booster, the spleen cells from
the immunized mice were fused with myeloma cells SP2/
0, and hybridoma supernatants were screened by indirect
ELISA as described below. Cells whose supernatants pro-
duced positive results in the ELISA were subcloned by
limiting dilution and further characterized by western blot
(described above) and confocal laser scanning microscopy.
Indirect ELISA
96-well plates were sensitized with 100 μL/well of purified
recombinant NS1 protein diluted in carbonate-bicarbonate
buffer (pH 9.6) at 4 °C overnight. After being blocked with
5 % skim milk in PBS for 1 h at 37 °C, the plates were incu-
bated with hybridoma supernatants for 1 h at 37 °C. Then,
the plates were incubated with a 1:40,000 dilution of HRP-
conjugated goat anti-mouse IgG (Sigma) for 1 h at 37 °C.
A substrate solution containing o-phenylenediamine
(OPD) was added for color development. Following a
15 min incubation, the enzymatic reaction was stopped by
the addition of 100 μL/well of 2 M H2SO4 and the absorb-
ance was measured at 490 nm using a Microplate Reader
(iMark, Bio-Rad Laboratories, Hercules, CA).
Confocal laser scanning microscopy
When 293T cells were approximately 70–80 % confluent,
the cells were transfected with eukaryotic recombinant
plasmids pCAGGs-NS1 by using transfection reagent
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(Invitrogen, Carlsbad, CA, USA) according to the manu-
facturer’s instructions. Thirty-six hours later, the cells
were fixed with 4 % polyoxymethylene in PBS overnight
at 4 °C. Then, 0.5 % Triton-X 100 in PBS was added to
permeabilize cells for 20 min at room temperature. The
microplates were blocked with 5 % skim milk in PBS for
30 min at room temperature. After being incubated with
hybridoma supernatants for 1 h at 37 °C, the microplates
were incubated with fluorescein isothiocyanate (FITC)-con-
jugated goat anti-mouse IgG (Santa Cruz Biotechnology,
Dallas, TX, USA) diluted in PBS containing 0.5 % Tween-
20 for 1 h at 37 °C, followed by DAPI (Sigma) diluted in
PBS for 5 min at 37 °C. After being rinsed three times with
PBS and mounted in PBS with 10 % glycerol, the micro-
plates were viewed under a fluorescence microscope (TCS
SP5, Leica Microsystems GmbH, Wetzlar, Germany).
Biopanning
A Ph.D.-7™ Phage Display Peptide Library Kit was pur-
chased from New England Biolabs Inc (Hitchin, Herts,
UK). Biopanning was done according to the manufacturer’s
instructions. Briefly, biopanning was carried out in 96-well
microtiter plates. One well was coated with 100 μg/mL
MAb in 0.1 M NaHCO3 (pH 8.6) overnight at 4 °C with
gentle agitation in a humidified container. Then, the well
was blocked with blocking buffer (0.1 M NaHCO3, pH 8.6,
containing 5 mg/mL BSA) at 4 °C for 2 h. The original
phage library diluted in TBST (50 mM Tris–HCl, pH 7.5,
150 mM NaCl plus 0.1 % Tween-20), containing 4 × 1010
pfu phage clones, was pipetted onto the coated well and
rocked gently for 1 h at room temperature. The unbound
phages were washed away, and the specifically-bound
phages were eluted with 0.2 M glycine-HCl (pH 2.2, con-
taining 1 mg/mL BSA) and were immediately neutralized
with 1 M Tris–HCl (pH 9.1). Approximately 1 μL of the
eluate was titered on LB/IPTG/Xgal plates for calculating
the ratio of output to input, and the rest was amplified by
adding it to ER2738 culture and incubating the culture for
4.5 h at 37 °C with vigorous shaking. The amplified eluates
were finally titered on LB/IPTG/Xgal plates for calculating
an input volume in the following rounds. In the two suc-
cessive rounds of biopanning, the MAb concentration was
reduced to 75 μg/mL and 50 μg/mL and the Tween-20
concentration in the wash steps was raised to 0.3 % and
0.5 %, respectively. After three rounds of biopanning, blue
plaques were stabbed from one of titering plates and amp-
lified in a tube containing ER2738 culture for use in a
phage ELISA and for sequencing as described below.
Phage ELISA
96-well plates were coated with 150 μL of 100 μg/mL
MAb in 0.1 M NaHCO3, pH 8.6, overnight at 4 °C. The
plates were completely filled with blocking buffer (0.1 M
NaHCO3, pH 8.6, containing 5 mg/mL BSA) at 4 °C for
2 h. Additionally, uncoated wells for each clone were
also blocked as negative controls. A second, fully un-
coated microtiter plate was blocked for use in serial dilu-
tions of phages before their addition to the coated wells.
Fourfold serial dilutions of the phage were carried out in
the separate blocked plate, starting with 1012 virions and
ending with 2 × 105 virions. Then, the dilutions were
transferred to both the coated and uncoated wells and
the plates were incubated at room temperature for 1 h
with agitation. HRP-conjugated anti-M13 monoclonal
antibody (GE Healthcare, Piscataway, NJ, USA) was
used as the secondary antibody at a 1:4,000 dilution
in blocking buffer at 37 °C for 1 h, followed by color
development with the substrate solution OPD. The
reaction was stopped after 15 min by adding 100 μL
of 2 M H2SO4 to each well, and then the absorbance
was measured at 490 nm on a Microplate Reader (iMark,
Bio-Rad Laboratories).
Sequencing of DNA displayed on the positive phages
Sequencing templates were purified using a purification
kit as described in the manufacturer’s instructions (New
England Biolabs). The DNA inserts were sequenced with
the -96gIII sequencing primer: 5′-CCCTCATAGTTAG
CGTAACG-3′. The amino acid sequences deduced from
the inserted nucleotide sequences were analyzed by
the DNASTAR Lasergene program.
Precise localization of the epitope
To verify if the identified motif represented an epitope
recognized by MAb D9, a series of complementary oligo-
nucleotides encoding for wild-type and truncated versions
of the motif WNDNTVRVS were synthesized, annealed,
and cloned into the BamHI/XhoI sites of the pGEX-6p-1
vector, producing a group of recombinant plasmids. After
DNA sequencing, the recombinant proteins were expressed
in E. coli BL21 (DE3) competent cells with the induction
of 0.8 mM IPTG. Eight segments with truncations at
the amino- or carboxy-termini of the motif WNDNTVRVS
were constructed to express the GST fusions GST-wildtype
(GST-wt), GST-wtΔS, GST-wtΔVS, GST-wtΔRVS, GST-
wtΔVRVS, GST-wtΔTVRVS, and GST-wtΔW-VRVS
representing WNDNTVRVS, WNDNTVRV, WNDNTVR,
WNDNTV, WNDNT, WNDN, and NDNT, respectively
(Table 3). Western blots were carried out as described
above to identify the reactivity with these polypeptides with
MAb D9 to determine the minimal unit of the epitope.
Detection of the reactivity of the identified epitope with
AIV-positive chicken sera
To determine whether the identified epitope could be
recognized by AIV-positive chicken sera, 96-well plates
were coated with the minimal epitope WNDNT (5 μg/
mL, 100 μL/well) diluted with the carbonate-bicarbonate
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buffer (pH 9.6) at 4 °C overnight and then blocked with
200 μL/well of 5 % skim milk diluted by PBS. After three
washes with PBST, AIV-positive chicken sera and AIV-
negative chicken sera (negative control) were added to
the plates at a 1:200 dilution and were incubated at
37 °C for 1 h. Next, 100 μL of anti-chicken IgY HRP-
conjugate (Sigma) at a 1:10000 dilution was added to
the plates after three washes with PBST and incubated at
37 °C for 1 h. The plates were then washed three times
and 100 μL/well of OPD was added. After 15 min of incu-
bation at room temperature, the reaction was stopped by
the addition of 100 μL/well of 2 M H2SO4 and the absorb-
ance was measured at 490 nm using a Microplate Reader
(iMark, Bio-Rad Laboratories).
Homology analysis
To investigate the conservation of the identified linear epi-
tope among AIV viruses, all sequences in the NCBI Influ-
enza Virus Sequence Database (http://www.ncbi.nlm.nih.
gov/genomes/FLU/FLU.html) were aligned using clustal
software. Based on the results of the alignment, four
mutant motifs were expressed as GST fusion pro-
teins (designated as GST-T186S, GST-N183S, GST-
D184G, and GST-D184N representing WNDNS, WSDNT,
WNGNT, and WNNNT) as above (Table 3) to investigate
whether amino acid substitutions at different sites affect
the ability of MAb D9 to react with the epitope.
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Table 3 The oligonucleotides coding for wild type and truncated or mutant motifs
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